Tech Translator

Li Hao sat in front of the simple table, and he saw the media reporters who came to the press conference. They have set up the camera positions and are ready to start the live broadcast at any time.

Some reporters have already taken out their portable laptops, ready to release news as the press conference progresses.

On Li Hao's left sat Zhou Yunsheng, and on Zhou Yunsheng's left was Wang Tong, the general manager of the biological company. On his right is Director Du Xianyu, and on Du Xianyu's right is Qian Minghua.

There were only five of them sitting at the front desk ready to be interviewed.

There is a separate table on the left side of the table, where Wei Tao sits. He is in charge of the process of the press conference.

Seeing that the time was ripe, Li Hao signaled for Wei Tao's press conference to officially begin.

Seeing Li Hao's gesture, Wei Tao clapped the microphone in his hand. There was a booming sound in the audience.

This is a reminder to reporters to let them know that the press conference has started, please concentrate.

After seeing that most of the media in the venue reacted, Wei Tao said with a smile: Welcome all media reporters to attend our company's press conference on artificial organs.

Now for the first item of the conference, Du Xianyu, Director of Biological Laboratory of Qingci Science and Technology, will introduce the brief situation of artificial organs.

After Du Xianyu heard it, he immediately sat up straight. Facing the media reporters below, he waved his hand and said, I am Du Xianyu, and I am in charge of the research and development of artificial organs.

I can assure you that the artificial organs we have developed have gone through a series of complicated tests. We also adopt our unique storage method to ensure that it is exactly the same as human organs before transplantation.

Our approach to the realization of artificial organs is mainly to obtain the patient's own highly active intact somatic cells, and cultivate them into pluripotent stem cells through a special culture method.

Use our company's unique technology to generate various organs as needed.

This is a simple application of cloning technology. Since the internal genetic material of the cells that make up the organ is identical, the cell surface antigens are identical.

It will not cause any rejection reaction, as long as the operation is successful, the artificial organ will function, and the patient will not feel any discomfort.

I believe that with the development of this technology, it can solve more than 90% of our human organ organic damage diseases one by one.

After Director Du Xianyu finished speaking, there was warm applause from the audience. Now people are advocating science. All the people present have great respect for scientists.

After seeing Du Xianyu's speech, Wei Tao immediately said, I'd like to invite Qian Minghua to speak. He is mainly responsible for medical research in the artificial organ project.

Qian Minghua glanced at the reporters in the audience, and he said with a smile: Through tens of thousands of successful operations, we have proved that artificial organs can function normally.

I will now focus on introducing what we call side effects and how to ensure that each artificial organ is fully active.

He paused, then continued: The content of the public service advertisement is limited, and it is impossible to specifically explain the side effects of artificial organs.

I can assure you that all organ functions explored by modern medicine can be realized by our artificial organs.

When we say that the mutual cooperation of organs is defective, it mainly refers to the mechanisms that have been discovered in modern medicine, but have not yet been studied to clarify the mechanisms by which organs communicate with each other and cooperate to deal with certain problems.

Since this situation has not been clearly understood in modern medicine, we cannot carry out targeted solutions.

In addition, our Chinese traditional Chinese medicine believes that organs not only have their own functions. They will also coordinate with each other to maintain health together.

By studying artificial organs, we have done detailed experiments on mice, pigs, and white rabbits.

Through the comparison of big data, the correctness of certain Chinese medicine theories has been found. However, we have not analyzed this mechanism of action through modern medicine, nor can we exert the body regulation function that traditional Chinese medicine believes that normal human organs have.

But as a disease treatment solution, our artificial organs can actually solve problems and save endangered patients.

With such a little side effect, there is no need to be afraid. After a serious illness, it is very difficult to return to the same health as before.

Patients receiving artificial organ transplants are advised not to exercise vigorously. Pay attention to light diet.

Seeing Qian Minghua gesturing to him, Wei Tao continued to pick up the microphone after he had finished speaking, Next, I would like to invite Wang Tong, the general manager of Qingci Biological Company, to introduce the output and price of artificial organs.

The reporters in the audience were listening to Du Xianyu and Qian Minghua talking. There are some things they don't quite understand.

But when Wei Tao finished speaking, he immediately raised his spirits. The output and price of artificial organs is a matter of great concern to everyone.

Wang Tong stood up, bowed to everyone in the audience, then sat down and said: I am in charge of the industrial production of artificial organs.

We have now established a fully intelligent production line for artificial organs. It produces 24 hours a day, and with sufficient raw materials, it can produce about 30,000 sets of artificial organs per day.

The fees for artificial organs are exactly the same for different organs, and the fee is charged at 100,000 yuan per group.

Each group we are talking about is one or more organs produced by the same cell.

Everyone in the audience was pleasantly surprised when they heard this output. 30,000 groups per day, which is far greater than the daily amount of organ donations in the world.

But they heard the fee of 100,000 yuan per group, and some people thought it was normal. Some people think this fee is very expensive.

There are also reporters whispering in the audience.

Each group is 100,000 yuan, according to the introduction of Qingci Technology. One kidney belongs to one group, and two kidneys also belong to one group. In this way, people who buy one kidney will not lose half of the money.

Your understanding is a bit wrong. They said that the organs produced by the same cell. Heart, liver, spleen, lung and kidney, all of these together will be called a group.

In this way, it is 100,000 yuan to replace the main organs of the whole body, and 100,000 yuan to replace only a single organ. I always feel that the latter loses a lot.

A soothing music sounded, and then Wei Tao's voice came: Please be quiet and abide by the discipline of our press conference. If you have any questions, please ask questions in the reporter's question session later.

Seeing the reporters quiet down, Wei Tao continued: Next, I would like to invite Zhou Yunsheng, the president of Qingci Technology, to introduce the issue of artificial organ export.

When everyone in the audience heard the news, they responded with all their energy. Especially foreign journalists.

Zhou Yunsheng picked up the microphone and said calmly to everyone: Our artificial organs will definitely be exported, but not the technology, but the products directly.

Our unique storage method can preserve the biological activity of artificial organs for one month.

With the current means of transportation, it can definitely be transported to any city with convenient transportation in the world.

When the clinical trials are completed, we will open the international application channel. This technology will benefit people all over the world.

After Zhou Yunsheng finished speaking, there was warm applause from the audience.